Endothelial microparticles, platelet and leukocyte activation and cellular interactions in patients with non-valvular atrial fibrillation.

被引：0
|
作者：
Chirinos, JA
Castrellon, A
Jy, W
Horstmann, LL
Jimenez, JJ
Willens, HJ
Castellanos, A
Myerburg, RJ
Ahn, YS
机构：
[1] Univ Miami, Miller Sch Med, Div Cardiol, Miami, FL 33152 USA
[2] Univ Miami, Miller Sch Med, Dept Med, Wallace H Coulter Platelet Lab, Miami, FL 33152 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2633
引用
收藏
页码：739A / 739A
页数：1
相关论文
共 50 条
  • [1] Endothelial microparticles, platelet, and leukocyte activation and cellular interactions in patients with nonvalvular atrial fibrillation
    Chirinos, Julio A.
    Castrellon, Aurelio
    Jy, Wenche
    Horstman, Lawrence L.
    Jimenez, Joaquin J.
    Veerani, Anila
    Castellanos, Agustin
    Myerburg, Robert J.
    Willens, Howard J.
    Ahn, Yeon S.
    CHEST, 2006, 130 (04) : 281S - 281S
  • [2] Utilization of warfarin in elderly patients with non-valvular atrial fibrillation.
    Youssef, H
    Pomerantz, SC
    Ciesielski, J
    Cavalieri, TA
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S112 - S112
  • [3] Left atrial platelet activation is increased in patients with non-valvular lone atrial fibrillation
    Lim, H. S.
    Willoughby, S. R.
    Schultz, C.
    Lau, D. H.
    Alasady, M.
    Leong, D. P.
    Brooks, A. G.
    Worthley, M. I.
    Young, G. D.
    Sanders, P.
    EUROPEAN HEART JOURNAL, 2010, 31 : 503 - 503
  • [4] Platelet activation promotes formation of platelet-leukocyte conjugates (PLC) in non-valvular atrial fibrillation (AF)
    Chirinos, JA
    Castrellon, A
    Zambrano, JP
    Jy, WC
    Horstman, LL
    Ahn, ER
    Jimenez, JJ
    Willens, H
    Castellanos, A
    Myerburg, RJ
    Ahn, YS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 100A - 100A
  • [5] Platelet activation promotes formation of platelet-leukocyte conjugates (PLC) in non-valvular atrial fibrillation (AF).
    Castrellon, A
    Chirinos, JA
    Zambrano, JP
    Jy, W
    Horstmann, LL
    Ahn, ER
    Jimenez, JJ
    Willens, H
    Castellanos, A
    Myerburg, RJ
    Ahn, YS
    BLOOD, 2004, 104 (11) : 957A - 957A
  • [6] PRESCRIPTION PATTERN AMONG ONCOLOGIC PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION.
    Toma, M.
    Giovinazzo, S.
    Sirello, D.
    Tini, G.
    La Malfa, G.
    Arboscello, E.
    Porto, I.
    Spallarossa, P.
    Ameri, P.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0G) : G21 - G22
  • [7] Ximelagatran, an oral direct thrombin inhibitor, normalizes platelet activation and inhibits thrombin generation in patients with non-valvular atrial fibrillation.
    Wolzt, M
    Bostrom, SL
    Wollbratt, M
    Svensson, M
    Eriksson, UG
    Grind, M
    Sarich, TC
    PHARMACOTHERAPY, 2002, 22 (10): : 1365 - 1365
  • [8] Patients with non-valvular atrial fibrillation have evidence of thrombin generation but not endothelial activation
    Obel, OA
    Al-Saady, N
    Fredericks, S
    Gallagher, M
    Waktare, J
    Camm, AJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 332A - 333A
  • [9] Therapeutic management of non-valvular atrial fibrillation. Update 2013
    Bode, K.
    Sommer, P.
    Bollmann, A.
    Hindricks, G.
    HERZ, 2013, 38 (07) : 743 - 755
  • [10] Value of transoesophageal echocardiography in the management of non-valvular atrial fibrillation.
    Baubion, N
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1996, 89 (10): : 1291 - 1295
12345